Several recent reports suggest that altered osteocyte function is manifested by changes in osteocytic FGF23, and dentin matrix acidic phosphoprotrein-1 (DMP1) and SOST expression are observed very early in the course of CKD (27). The gene discussed is FGF23; the disease is chronic kidney disease.